CMS Administrator Dr. Mehmet Oz recently expressed his support for the use of GLP-1 (glucagon-like peptide-1) medications, such as Ozempic, for appropriate uses. In an interview with Fox News Digital, Dr. Oz stated that these medications can help individuals who are overweight lose weight effectively, but emphasized that they are not a replacement for diet and exercise.

Benefits of GLP-1 Medications

Dr. Oz noted that GLP-1 medications can be particularly helpful for those who have trouble moving due to joint pain or are experiencing internal dysfunction. He also highlighted that certain GLP-1 drugs are covered by Medicare for overweight candidates with certain conditions, such as high blood pressure and diabetes.

According to Dr. Oz, the use of GLP-1 medications can lead to significant cost savings for taxpayers, as they can help reduce the incidence of chronic conditions like high blood pressure and diabetes. He estimated that about 70% of healthcare spending is attributed to chronic conditions, with obesity being the primary driver.

Medicare GLP-1 Bridge Program

Dr. Oz recently announced the launch of the Medicare GLP-1 Bridge program, which will allow more seniors to access GLP-1 drugs for a monthly cost of $50, provided they meet qualifying health criteria and receive prior authorization from a doctor. This program aims to increase access to these medications for individuals who may not have previously qualified due to lack of certain conditions.

While Dr. Oz acknowledges that GLP-1 medications are not a ‘silver bullet’ for weight loss and chronic disease management, he believes that combining these medications with foundational health practices, such as eating right, exercising, and managing stress, can lead to better health outcomes.

Original reporting: Fox News (HLL/CB) — read the source article.